Detalles de la búsqueda
1.
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
J Pathol
; 236(4): 517-30, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25875424
2.
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
BMC Cancer
; 14: 352, 2014 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24886074
3.
Downregulation of androgen receptor transcription by promoter g-quadruplex stabilization as a potential alternative treatment for castrate-resistant prostate cancer.
Biochemistry
; 52(8): 1429-36, 2013 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23363071
4.
Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
EMBO Mol Med
; 10(3)2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437778
5.
Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells.
Oncotarget
; 5(11): 3785-99, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003216
6.
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.
EMBO Mol Med
; 6(5): 651-61, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24737870
7.
MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.
Mol Cell Biol
; 32(3): 633-51, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22144583
Resultados
1 -
7
de 7
1
Próxima >
>>